nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ALB—Auranofin—psoriatic arthritis	0.237	0.269	CbGbCtD
Alfentanil—ALB—Prednisone—psoriatic arthritis	0.0755	0.0858	CbGbCtD
Alfentanil—ABCB1—Methylprednisolone—psoriatic arthritis	0.0652	0.074	CbGbCtD
Alfentanil—CYP3A7—Dexamethasone—psoriatic arthritis	0.0505	0.0574	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0505	0.0574	CbGbCtD
Alfentanil—ABCB1—Betamethasone—psoriatic arthritis	0.0424	0.0481	CbGbCtD
Alfentanil—ABCB1—Prednisolone—psoriatic arthritis	0.0418	0.0475	CbGbCtD
Alfentanil—ABCB1—Prednisone—psoriatic arthritis	0.0395	0.0449	CbGbCtD
Alfentanil—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0391	0.0444	CbGbCtD
Alfentanil—CYP3A5—Dexamethasone—psoriatic arthritis	0.0379	0.043	CbGbCtD
Alfentanil—ALB—Methotrexate—psoriatic arthritis	0.0379	0.043	CbGbCtD
Alfentanil—CYP3A4—Triamcinolone—psoriatic arthritis	0.0296	0.0336	CbGbCtD
Alfentanil—CYP3A4—Betamethasone—psoriatic arthritis	0.0254	0.0288	CbGbCtD
Alfentanil—CYP3A4—Prednisolone—psoriatic arthritis	0.0251	0.0285	CbGbCtD
Alfentanil—ABCB1—Dexamethasone—psoriatic arthritis	0.0247	0.028	CbGbCtD
Alfentanil—CYP3A4—Prednisone—psoriatic arthritis	0.0237	0.0269	CbGbCtD
Alfentanil—ABCB1—Methotrexate—psoriatic arthritis	0.0198	0.0225	CbGbCtD
Alfentanil—CYP3A4—Dexamethasone—psoriatic arthritis	0.0148	0.0168	CbGbCtD
Alfentanil—Drug dependence—Methylprednisolone—psoriatic arthritis	0.00393	0.0328	CcSEcCtD
Alfentanil—Drug dependence—Dexamethasone—psoriatic arthritis	0.00357	0.0299	CcSEcCtD
Alfentanil—Drug dependence—Betamethasone—psoriatic arthritis	0.00357	0.0299	CcSEcCtD
Alfentanil—Drug dependence—Prednisone—psoriatic arthritis	0.00311	0.026	CcSEcCtD
Alfentanil—Visual impairment—Auranofin—psoriatic arthritis	0.0018	0.0151	CcSEcCtD
Alfentanil—Eye disorder—Auranofin—psoriatic arthritis	0.00175	0.0146	CcSEcCtD
Alfentanil—Dermatitis atopic—Prednisolone—psoriatic arthritis	0.00161	0.0134	CcSEcCtD
Alfentanil—Dermatitis atopic—Triamcinolone—psoriatic arthritis	0.00148	0.0123	CcSEcCtD
Alfentanil—Hiccups—Prednisolone—psoriatic arthritis	0.00119	0.00993	CcSEcCtD
Alfentanil—Dermatitis atopic—Prednisone—psoriatic arthritis	0.00117	0.00975	CcSEcCtD
Alfentanil—Hiccups—Triamcinolone—psoriatic arthritis	0.00109	0.00913	CcSEcCtD
Alfentanil—Hiccups—Methylprednisolone—psoriatic arthritis	0.00109	0.00911	CcSEcCtD
Alfentanil—Urticaria—Auranofin—psoriatic arthritis	0.00106	0.00883	CcSEcCtD
Alfentanil—Euphoric mood—Prednisolone—psoriatic arthritis	0.00102	0.00853	CcSEcCtD
Alfentanil—Hiccups—Dexamethasone—psoriatic arthritis	0.000992	0.00829	CcSEcCtD
Alfentanil—Hiccups—Betamethasone—psoriatic arthritis	0.000992	0.00829	CcSEcCtD
Alfentanil—Pruritus—Auranofin—psoriatic arthritis	0.000941	0.00786	CcSEcCtD
Alfentanil—Euphoric mood—Triamcinolone—psoriatic arthritis	0.000939	0.00785	CcSEcCtD
Alfentanil—Euphoric mood—Methylprednisolone—psoriatic arthritis	0.000937	0.00783	CcSEcCtD
Alfentanil—Visual disturbance—Prednisolone—psoriatic arthritis	0.00091	0.00761	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Prednisolone—psoriatic arthritis	0.000891	0.00745	CcSEcCtD
Alfentanil—Hiccups—Prednisone—psoriatic arthritis	0.000863	0.00722	CcSEcCtD
Alfentanil—Euphoric mood—Dexamethasone—psoriatic arthritis	0.000852	0.00712	CcSEcCtD
Alfentanil—Euphoric mood—Betamethasone—psoriatic arthritis	0.000852	0.00712	CcSEcCtD
Alfentanil—Apnoea—Methotrexate—psoriatic arthritis	0.000851	0.00711	CcSEcCtD
Alfentanil—Vomiting—Auranofin—psoriatic arthritis	0.000845	0.00706	CcSEcCtD
Alfentanil—Rash—Auranofin—psoriatic arthritis	0.000838	0.00701	CcSEcCtD
Alfentanil—Dermatitis—Auranofin—psoriatic arthritis	0.000838	0.007	CcSEcCtD
Alfentanil—Cardiac arrest—Prednisolone—psoriatic arthritis	0.00082	0.00685	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.00082	0.00685	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.000818	0.00683	CcSEcCtD
Alfentanil—Nausea—Auranofin—psoriatic arthritis	0.00079	0.0066	CcSEcCtD
Alfentanil—Visual disturbance—Betamethasone—psoriatic arthritis	0.000759	0.00635	CcSEcCtD
Alfentanil—Visual disturbance—Dexamethasone—psoriatic arthritis	0.000759	0.00635	CcSEcCtD
Alfentanil—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.000754	0.0063	CcSEcCtD
Alfentanil—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.000753	0.00629	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.000744	0.00621	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.000744	0.00621	CcSEcCtD
Alfentanil—Euphoric mood—Prednisone—psoriatic arthritis	0.000742	0.0062	CcSEcCtD
Alfentanil—Cardiac arrest—Betamethasone—psoriatic arthritis	0.000684	0.00572	CcSEcCtD
Alfentanil—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.000684	0.00572	CcSEcCtD
Alfentanil—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.000673	0.00562	CcSEcCtD
Alfentanil—Bradycardia—Prednisolone—psoriatic arthritis	0.000607	0.00508	CcSEcCtD
Alfentanil—Cardiac arrest—Prednisone—psoriatic arthritis	0.000596	0.00498	CcSEcCtD
Alfentanil—Epistaxis—Triamcinolone—psoriatic arthritis	0.000577	0.00482	CcSEcCtD
Alfentanil—Visual impairment—Prednisolone—psoriatic arthritis	0.000575	0.00481	CcSEcCtD
Alfentanil—Bradycardia—Triamcinolone—psoriatic arthritis	0.000559	0.00467	CcSEcCtD
Alfentanil—Bradycardia—Methylprednisolone—psoriatic arthritis	0.000557	0.00466	CcSEcCtD
Alfentanil—Visual disturbance—Methotrexate—psoriatic arthritis	0.000553	0.00462	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.000541	0.00452	CcSEcCtD
Alfentanil—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000538	0.0045	CcSEcCtD
Alfentanil—Arrhythmia—Prednisolone—psoriatic arthritis	0.000533	0.00445	CcSEcCtD
Alfentanil—Visual impairment—Methylprednisolone—psoriatic arthritis	0.000528	0.00441	CcSEcCtD
Alfentanil—Erythema—Prednisolone—psoriatic arthritis	0.000519	0.00434	CcSEcCtD
Alfentanil—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000512	0.00428	CcSEcCtD
Alfentanil—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000508	0.00425	CcSEcCtD
Alfentanil—Bradycardia—Betamethasone—psoriatic arthritis	0.000507	0.00424	CcSEcCtD
Alfentanil—Bradycardia—Dexamethasone—psoriatic arthritis	0.000507	0.00424	CcSEcCtD
Alfentanil—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000497	0.00415	CcSEcCtD
Alfentanil—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000495	0.00413	CcSEcCtD
Alfentanil—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000493	0.00412	CcSEcCtD
Alfentanil—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00049	0.0041	CcSEcCtD
Alfentanil—Vision blurred—Prednisolone—psoriatic arthritis	0.00049	0.00409	CcSEcCtD
Alfentanil—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.000489	0.00409	CcSEcCtD
Alfentanil—Visual impairment—Betamethasone—psoriatic arthritis	0.00048	0.00401	CcSEcCtD
Alfentanil—Visual impairment—Dexamethasone—psoriatic arthritis	0.00048	0.00401	CcSEcCtD
Alfentanil—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00048	0.00401	CcSEcCtD
Alfentanil—Erythema—Triamcinolone—psoriatic arthritis	0.000478	0.00399	CcSEcCtD
Alfentanil—Erythema—Methylprednisolone—psoriatic arthritis	0.000477	0.00398	CcSEcCtD
Alfentanil—Eye disorder—Betamethasone—psoriatic arthritis	0.000465	0.00389	CcSEcCtD
Alfentanil—Eye disorder—Dexamethasone—psoriatic arthritis	0.000465	0.00389	CcSEcCtD
Alfentanil—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000457	0.00382	CcSEcCtD
Alfentanil—Angiopathy—Betamethasone—psoriatic arthritis	0.000452	0.00378	CcSEcCtD
Alfentanil—Angiopathy—Dexamethasone—psoriatic arthritis	0.000452	0.00378	CcSEcCtD
Alfentanil—Convulsion—Prednisolone—psoriatic arthritis	0.00045	0.00376	CcSEcCtD
Alfentanil—Hypertension—Prednisolone—psoriatic arthritis	0.000448	0.00375	CcSEcCtD
Alfentanil—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000445	0.00372	CcSEcCtD
Alfentanil—Arrhythmia—Betamethasone—psoriatic arthritis	0.000445	0.00372	CcSEcCtD
Alfentanil—Bradycardia—Prednisone—psoriatic arthritis	0.000441	0.00369	CcSEcCtD
Alfentanil—Erythema—Dexamethasone—psoriatic arthritis	0.000433	0.00362	CcSEcCtD
Alfentanil—Erythema—Betamethasone—psoriatic arthritis	0.000433	0.00362	CcSEcCtD
Alfentanil—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000426	0.00356	CcSEcCtD
Alfentanil—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000424	0.00354	CcSEcCtD
Alfentanil—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00042	0.00351	CcSEcCtD
Alfentanil—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000419	0.0035	CcSEcCtD
Alfentanil—Cough—Triamcinolone—psoriatic arthritis	0.000417	0.00348	CcSEcCtD
Alfentanil—Convulsion—Triamcinolone—psoriatic arthritis	0.000414	0.00346	CcSEcCtD
Alfentanil—Tachycardia—Prednisolone—psoriatic arthritis	0.000414	0.00346	CcSEcCtD
Alfentanil—Convulsion—Methylprednisolone—psoriatic arthritis	0.000413	0.00345	CcSEcCtD
Alfentanil—Hypertension—Triamcinolone—psoriatic arthritis	0.000412	0.00345	CcSEcCtD
Alfentanil—Hypertension—Methylprednisolone—psoriatic arthritis	0.000411	0.00344	CcSEcCtD
Alfentanil—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00041	0.00343	CcSEcCtD
Alfentanil—Eye disorder—Prednisone—psoriatic arthritis	0.000405	0.00339	CcSEcCtD
Alfentanil—Drowsiness—Methotrexate—psoriatic arthritis	0.000404	0.00337	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000403	0.00337	CcSEcCtD
Alfentanil—Angiopathy—Prednisone—psoriatic arthritis	0.000393	0.00329	CcSEcCtD
Alfentanil—Confusional state—Methylprednisolone—psoriatic arthritis	0.000392	0.00328	CcSEcCtD
Alfentanil—Immune system disorder—Prednisone—psoriatic arthritis	0.000392	0.00327	CcSEcCtD
Alfentanil—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00039	0.00326	CcSEcCtD
Alfentanil—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000389	0.00325	CcSEcCtD
Alfentanil—Arrhythmia—Prednisone—psoriatic arthritis	0.000387	0.00324	CcSEcCtD
Alfentanil—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000381	0.00319	CcSEcCtD
Alfentanil—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000381	0.00318	CcSEcCtD
Alfentanil—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000381	0.00318	CcSEcCtD
Alfentanil—Epistaxis—Methotrexate—psoriatic arthritis	0.000381	0.00318	CcSEcCtD
Alfentanil—Tachycardia—Triamcinolone—psoriatic arthritis	0.00038	0.00318	CcSEcCtD
Alfentanil—Mental disorder—Prednisone—psoriatic arthritis	0.00038	0.00317	CcSEcCtD
Alfentanil—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00038	0.00317	CcSEcCtD
Alfentanil—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000378	0.00316	CcSEcCtD
Alfentanil—Erythema—Prednisone—psoriatic arthritis	0.000377	0.00315	CcSEcCtD
Alfentanil—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000377	0.00315	CcSEcCtD
Alfentanil—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000376	0.00314	CcSEcCtD
Alfentanil—Convulsion—Dexamethasone—psoriatic arthritis	0.000376	0.00314	CcSEcCtD
Alfentanil—Convulsion—Betamethasone—psoriatic arthritis	0.000376	0.00314	CcSEcCtD
Alfentanil—Hypertension—Dexamethasone—psoriatic arthritis	0.000374	0.00313	CcSEcCtD
Alfentanil—Hypertension—Betamethasone—psoriatic arthritis	0.000374	0.00313	CcSEcCtD
Alfentanil—Hypotension—Methylprednisolone—psoriatic arthritis	0.000363	0.00304	CcSEcCtD
Alfentanil—Pain—Prednisolone—psoriatic arthritis	0.000363	0.00303	CcSEcCtD
Alfentanil—Vision blurred—Prednisone—psoriatic arthritis	0.000356	0.00297	CcSEcCtD
Alfentanil—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000354	0.00296	CcSEcCtD
Alfentanil—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000354	0.00296	CcSEcCtD
Alfentanil—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000349	0.00292	CcSEcCtD
Alfentanil—Visual impairment—Methotrexate—psoriatic arthritis	0.000349	0.00292	CcSEcCtD
Alfentanil—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000347	0.0029	CcSEcCtD
Alfentanil—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000347	0.0029	CcSEcCtD
Alfentanil—Agitation—Prednisone—psoriatic arthritis	0.000347	0.0029	CcSEcCtD
Alfentanil—Tachycardia—Dexamethasone—psoriatic arthritis	0.000345	0.00289	CcSEcCtD
Alfentanil—Tachycardia—Betamethasone—psoriatic arthritis	0.000345	0.00289	CcSEcCtD
Alfentanil—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000342	0.00286	CcSEcCtD
Alfentanil—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000342	0.00286	CcSEcCtD
Alfentanil—Eye disorder—Methotrexate—psoriatic arthritis	0.000339	0.00283	CcSEcCtD
Alfentanil—Urticaria—Prednisolone—psoriatic arthritis	0.000337	0.00281	CcSEcCtD
Alfentanil—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000336	0.00281	CcSEcCtD
Alfentanil—Fatigue—Triamcinolone—psoriatic arthritis	0.000336	0.00281	CcSEcCtD
Alfentanil—Fatigue—Methylprednisolone—psoriatic arthritis	0.000335	0.0028	CcSEcCtD
Alfentanil—Pain—Triamcinolone—psoriatic arthritis	0.000333	0.00279	CcSEcCtD
Alfentanil—Loss of consciousness—Prednisone—psoriatic arthritis	0.000332	0.00277	CcSEcCtD
Alfentanil—Hypotension—Dexamethasone—psoriatic arthritis	0.000331	0.00276	CcSEcCtD
Alfentanil—Hypotension—Betamethasone—psoriatic arthritis	0.000331	0.00276	CcSEcCtD
Alfentanil—Angiopathy—Methotrexate—psoriatic arthritis	0.000329	0.00275	CcSEcCtD
Alfentanil—Immune system disorder—Methotrexate—psoriatic arthritis	0.000327	0.00274	CcSEcCtD
Alfentanil—Convulsion—Prednisone—psoriatic arthritis	0.000327	0.00273	CcSEcCtD
Alfentanil—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000327	0.00273	CcSEcCtD
Alfentanil—Hypertension—Prednisone—psoriatic arthritis	0.000326	0.00272	CcSEcCtD
Alfentanil—Chills—Methotrexate—psoriatic arthritis	0.000325	0.00272	CcSEcCtD
Alfentanil—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000321	0.00268	CcSEcCtD
Alfentanil—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000321	0.00268	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000319	0.00267	CcSEcCtD
Alfentanil—Mental disorder—Methotrexate—psoriatic arthritis	0.000317	0.00265	CcSEcCtD
Alfentanil—Erythema—Methotrexate—psoriatic arthritis	0.000315	0.00264	CcSEcCtD
Alfentanil—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000312	0.00261	CcSEcCtD
Alfentanil—Urticaria—Triamcinolone—psoriatic arthritis	0.00031	0.00259	CcSEcCtD
Alfentanil—Urticaria—Methylprednisolone—psoriatic arthritis	0.000309	0.00258	CcSEcCtD
Alfentanil—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000308	0.00258	CcSEcCtD
Alfentanil—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000308	0.00257	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000305	0.00255	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000305	0.00255	CcSEcCtD
Alfentanil—Fatigue—Betamethasone—psoriatic arthritis	0.000305	0.00255	CcSEcCtD
Alfentanil—Fatigue—Dexamethasone—psoriatic arthritis	0.000305	0.00255	CcSEcCtD
Alfentanil—Pain—Betamethasone—psoriatic arthritis	0.000302	0.00253	CcSEcCtD
Alfentanil—Pain—Dexamethasone—psoriatic arthritis	0.000302	0.00253	CcSEcCtD
Alfentanil—Nervous system disorder—Prednisone—psoriatic arthritis	0.000302	0.00252	CcSEcCtD
Alfentanil—Tachycardia—Prednisone—psoriatic arthritis	0.000301	0.00251	CcSEcCtD
Alfentanil—Skin disorder—Prednisone—psoriatic arthritis	0.000299	0.0025	CcSEcCtD
Alfentanil—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000298	0.00249	CcSEcCtD
Alfentanil—Vision blurred—Methotrexate—psoriatic arthritis	0.000297	0.00248	CcSEcCtD
Alfentanil—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000291	0.00244	CcSEcCtD
Alfentanil—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000291	0.00244	CcSEcCtD
Alfentanil—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000287	0.0024	CcSEcCtD
Alfentanil—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000287	0.0024	CcSEcCtD
Alfentanil—Urticaria—Dexamethasone—psoriatic arthritis	0.000281	0.00235	CcSEcCtD
Alfentanil—Urticaria—Betamethasone—psoriatic arthritis	0.000281	0.00235	CcSEcCtD
Alfentanil—Dizziness—Prednisolone—psoriatic arthritis	0.00028	0.00234	CcSEcCtD
Alfentanil—Asthenia—Triamcinolone—psoriatic arthritis	0.00028	0.00234	CcSEcCtD
Alfentanil—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00028	0.00234	CcSEcCtD
Alfentanil—Body temperature increased—Betamethasone—psoriatic arthritis	0.00028	0.00234	CcSEcCtD
Alfentanil—Asthenia—Methylprednisolone—psoriatic arthritis	0.000279	0.00233	CcSEcCtD
Alfentanil—Pruritus—Triamcinolone—psoriatic arthritis	0.000276	0.00231	CcSEcCtD
Alfentanil—Cough—Methotrexate—psoriatic arthritis	0.000275	0.0023	CcSEcCtD
Alfentanil—Pruritus—Methylprednisolone—psoriatic arthritis	0.000275	0.0023	CcSEcCtD
Alfentanil—Convulsion—Methotrexate—psoriatic arthritis	0.000273	0.00228	CcSEcCtD
Alfentanil—Rash—Prednisolone—psoriatic arthritis	0.000267	0.00223	CcSEcCtD
Alfentanil—Dermatitis—Prednisolone—psoriatic arthritis	0.000267	0.00223	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000267	0.00223	CcSEcCtD
Alfentanil—Fatigue—Prednisone—psoriatic arthritis	0.000266	0.00222	CcSEcCtD
Alfentanil—Headache—Prednisolone—psoriatic arthritis	0.000266	0.00222	CcSEcCtD
Alfentanil—Confusional state—Methotrexate—psoriatic arthritis	0.00026	0.00217	CcSEcCtD
Alfentanil—Dizziness—Triamcinolone—psoriatic arthritis	0.000258	0.00215	CcSEcCtD
Alfentanil—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000257	0.00215	CcSEcCtD
Alfentanil—Dizziness—Methylprednisolone—psoriatic arthritis	0.000257	0.00215	CcSEcCtD
Alfentanil—Feeling abnormal—Prednisone—psoriatic arthritis	0.000254	0.00212	CcSEcCtD
Alfentanil—Asthenia—Dexamethasone—psoriatic arthritis	0.000254	0.00212	CcSEcCtD
Alfentanil—Asthenia—Betamethasone—psoriatic arthritis	0.000254	0.00212	CcSEcCtD
Alfentanil—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000252	0.00211	CcSEcCtD
Alfentanil—Nausea—Prednisolone—psoriatic arthritis	0.000252	0.0021	CcSEcCtD
Alfentanil—Pruritus—Betamethasone—psoriatic arthritis	0.00025	0.00209	CcSEcCtD
Alfentanil—Pruritus—Dexamethasone—psoriatic arthritis	0.00025	0.00209	CcSEcCtD
Alfentanil—Skin disorder—Methotrexate—psoriatic arthritis	0.00025	0.00209	CcSEcCtD
Alfentanil—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000249	0.00208	CcSEcCtD
Alfentanil—Vomiting—Triamcinolone—psoriatic arthritis	0.000248	0.00207	CcSEcCtD
Alfentanil—Vomiting—Methylprednisolone—psoriatic arthritis	0.000247	0.00207	CcSEcCtD
Alfentanil—Rash—Triamcinolone—psoriatic arthritis	0.000246	0.00205	CcSEcCtD
Alfentanil—Dermatitis—Triamcinolone—psoriatic arthritis	0.000246	0.00205	CcSEcCtD
Alfentanil—Rash—Methylprednisolone—psoriatic arthritis	0.000245	0.00205	CcSEcCtD
Alfentanil—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000245	0.00205	CcSEcCtD
Alfentanil—Urticaria—Prednisone—psoriatic arthritis	0.000245	0.00205	CcSEcCtD
Alfentanil—Headache—Triamcinolone—psoriatic arthritis	0.000244	0.00204	CcSEcCtD
Alfentanil—Headache—Methylprednisolone—psoriatic arthritis	0.000244	0.00204	CcSEcCtD
Alfentanil—Body temperature increased—Prednisone—psoriatic arthritis	0.000244	0.00204	CcSEcCtD
Alfentanil—Hypotension—Methotrexate—psoriatic arthritis	0.000241	0.00201	CcSEcCtD
Alfentanil—Dizziness—Betamethasone—psoriatic arthritis	0.000234	0.00195	CcSEcCtD
Alfentanil—Dizziness—Dexamethasone—psoriatic arthritis	0.000234	0.00195	CcSEcCtD
Alfentanil—Nausea—Triamcinolone—psoriatic arthritis	0.000232	0.00194	CcSEcCtD
Alfentanil—Nausea—Methylprednisolone—psoriatic arthritis	0.000231	0.00193	CcSEcCtD
Alfentanil—Somnolence—Methotrexate—psoriatic arthritis	0.000229	0.00191	CcSEcCtD
Alfentanil—Hypersensitivity—Prednisone—psoriatic arthritis	0.000227	0.0019	CcSEcCtD
Alfentanil—Vomiting—Betamethasone—psoriatic arthritis	0.000225	0.00188	CcSEcCtD
Alfentanil—Vomiting—Dexamethasone—psoriatic arthritis	0.000225	0.00188	CcSEcCtD
Alfentanil—Rash—Dexamethasone—psoriatic arthritis	0.000223	0.00186	CcSEcCtD
Alfentanil—Rash—Betamethasone—psoriatic arthritis	0.000223	0.00186	CcSEcCtD
Alfentanil—Dermatitis—Dexamethasone—psoriatic arthritis	0.000223	0.00186	CcSEcCtD
Alfentanil—Dermatitis—Betamethasone—psoriatic arthritis	0.000223	0.00186	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000222	0.00186	CcSEcCtD
Alfentanil—Fatigue—Methotrexate—psoriatic arthritis	0.000222	0.00186	CcSEcCtD
Alfentanil—Headache—Dexamethasone—psoriatic arthritis	0.000222	0.00185	CcSEcCtD
Alfentanil—Headache—Betamethasone—psoriatic arthritis	0.000222	0.00185	CcSEcCtD
Alfentanil—Asthenia—Prednisone—psoriatic arthritis	0.000221	0.00185	CcSEcCtD
Alfentanil—Pain—Methotrexate—psoriatic arthritis	0.00022	0.00184	CcSEcCtD
Alfentanil—Pruritus—Prednisone—psoriatic arthritis	0.000218	0.00182	CcSEcCtD
Alfentanil—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000212	0.00177	CcSEcCtD
Alfentanil—Nausea—Betamethasone—psoriatic arthritis	0.00021	0.00176	CcSEcCtD
Alfentanil—Nausea—Dexamethasone—psoriatic arthritis	0.00021	0.00176	CcSEcCtD
Alfentanil—Urticaria—Methotrexate—psoriatic arthritis	0.000205	0.00171	CcSEcCtD
Alfentanil—Dizziness—Prednisone—psoriatic arthritis	0.000204	0.0017	CcSEcCtD
Alfentanil—Body temperature increased—Methotrexate—psoriatic arthritis	0.000204	0.0017	CcSEcCtD
Alfentanil—Vomiting—Prednisone—psoriatic arthritis	0.000196	0.00164	CcSEcCtD
Alfentanil—Rash—Prednisone—psoriatic arthritis	0.000194	0.00162	CcSEcCtD
Alfentanil—Dermatitis—Prednisone—psoriatic arthritis	0.000194	0.00162	CcSEcCtD
Alfentanil—Headache—Prednisone—psoriatic arthritis	0.000193	0.00161	CcSEcCtD
Alfentanil—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00019	0.00159	CcSEcCtD
Alfentanil—Asthenia—Methotrexate—psoriatic arthritis	0.000185	0.00154	CcSEcCtD
Alfentanil—Nausea—Prednisone—psoriatic arthritis	0.000183	0.00153	CcSEcCtD
Alfentanil—Pruritus—Methotrexate—psoriatic arthritis	0.000182	0.00152	CcSEcCtD
Alfentanil—Dizziness—Methotrexate—psoriatic arthritis	0.00017	0.00142	CcSEcCtD
Alfentanil—Vomiting—Methotrexate—psoriatic arthritis	0.000164	0.00137	CcSEcCtD
Alfentanil—Rash—Methotrexate—psoriatic arthritis	0.000162	0.00136	CcSEcCtD
Alfentanil—Dermatitis—Methotrexate—psoriatic arthritis	0.000162	0.00136	CcSEcCtD
Alfentanil—Headache—Methotrexate—psoriatic arthritis	0.000161	0.00135	CcSEcCtD
Alfentanil—Nausea—Methotrexate—psoriatic arthritis	0.000153	0.00128	CcSEcCtD
